Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9049-9059

  Julithe, Romain ^a   Abou Jaoudé, Georges ^a   Sureau, Camille ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARAGINE; ENVELOPE PROTEIN; GLYCAN; ISOPROTEIN; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; INFECTION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; CELL LINE; CELL LINE, TUMOR; GLYCOSYLATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS INTERNALIZATION;

EID: 84904908463     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01161-14     Document Type: Article

References (41)

1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. 2012. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212-2219. http://dx.doi.org/10.1016/j.vaccine.2011.12.116.
2. Bruss V. 2007. Hepatitis B virus morphogenesis. World J. Gastroenterol. 13:65-73. http://dx.doi.org/10.3748/wjg.v13.i1.65.
3. Bonino F, Heermann KH, Rizzetto M, Gerlich WH. 1986. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virusderived envelope. J. Virol. 58:945-950.
4. Persson B, Argos P. 1994. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J. Mol. Biol. 237:182-192. http://dx.doi.org/10.1006/jmbi.1994.1220.
5. Stirk HJ, Thornton JM, Howard CR. 1992. A topological model for hepatitis B surface antigen. Intervirology 33:148-158.
6. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309. http://dx.doi.org/10.1159/000080872.
7. Zanetti AR, Van Damme P, Shouval D. 2008. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26:6266-6273. http://dx.doi.org/10.1016/j.vaccine.2008.09.056.
8. Salisse J, Sureau C. 2009. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J. Virol. 83:9321-9328. http://dx.doi.org/10.1128/JVI.00678-09.
9. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049. http://dx.doi.org/10.7554/eLife.00049.
10. Schmitt S, Glebe D, Alving K, Tolle TK, Linder M, Geyer H, Linder D, Peter-Katalinic J, Gerlich WH, Geyer R. 1999. Analysis of the pre-S2 Nand O-linked glycans of the M surface protein from human hepatitis B virus. J. Biol. Chem. 274:11945-11957. http://dx.doi.org/10.1074/jbc.274.17.11945.
11. Block TM, Lu X, Platt FM, Foster GR, Gerlich WH, Blumberg BS, Dwek RA. 1994. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci. U. S. A. 91:2235-2239. http://dx.doi.org/10.1073/pnas.91.6.2235.
12. Anjum S, Wahid A, Afzal MS, Albecka A, Alsaleh K, Ahmad T, Baumert TF, Wychowski C, Qadri I, Penin F, Dubuisson J. 2013. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitisCvirus protects against virus neutralization. J. Infect. Dis. 208:1888-1897. http://dx.doi.org/10.1093/infdis/jit376.
13. Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15:211-218. http://dx.doi.org/10.1016/j.tim.2007.03.003.
14. Reitter JN, Means RE, Desrosiers RC. 1998. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4:679-684. http://dx.doi.org/10.1038/nm0698-679.
15. Yu DM, Li XH, Mom V, Lu ZH, Liao XW, Han Y, Pichoud C, Gong QM, Zhang DH, Zhang Y, Deny P, Zoulim F, Zhang XX. 2014. N-Glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape. J. Hepatol. 60:515-522. http://dx.doi.org/10.1016/j.jhep.2013.11.004.
16. Mehta A, Lu X, Block TM, Blumberg BS, Dwek RA. 1997. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. U. S. A. 94: 1822-1827. http://dx.doi.org/10.1073/pnas.94.5.1822.
17. Sureau C, Fournier-Wirth C, Maurel P. 2003. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus. J. Virol. 77:5519-5523. http://dx.doi.org/10.1128/JVI.77.9.5519-5523.2003.
18. Wang CJ, Sung SY, Chen DS, Chen PJ. 1996. N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus. Virology 220:28-36. http://dx.doi.org/10.1006/viro.1996.0282.
19. Ito K, Qin Y, Guarnieri M, Garcia T, Kwei K, Mizokami M, Zhang J, Li J, Wands JR, Tong S. 2010. Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J. Virol. 84:12850-12861. http://dx.doi.org/10.1128/JVI.01499-10.
20. Kuo MY, Chao M, Taylor J. 1989. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J. Virol. 63:1945-1950.
21. Blanchet M, Sureau C. 2006. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J. Virol. 80:11935-11945. http://dx.doi.org/10.1128/JVI.00621-06.
22. Jenna S, Sureau C. 1999. Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles. J. Virol. 73:3351-3358.
23. Blanchet M, Sureau C. 2007. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J. Virol. 81:5841-5849. http://dx.doi.org/10.1128/JVI.00096-07.
24. Peterson DL, Paul DA, Lam J, Tribby II, Achord DT. 1984. Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies. J. Immunol. 132:920-927.
25. Jenna S, Sureau C. 1998. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus. Virology 251:176-186. http://dx.doi.org/10.1006/viro.1998.9391.
26. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. 2002. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. U. S. A. 99:15655-15660. http://dx.doi.org/10.1073/pnas.232137699.
27. Sureau C. 2010. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model. Methods Mol. Biol. 640:463-473. http://dx.doi.org/10.1007/978-1-60761-688-7_25.
28. Shearer MH, Sureau C, Dunbar B, Kennedy RC. 1998. Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen. Mol. Immunol. 35:1149-1160. http://dx.doi.org/10.1016/S0161-5890(98)00110-2.
29. Paulij WP, de Wit PL, Sunnen CM, van Roosmalen MH, Petersen-van Ettekoven A, Cooreman MP, Heijtink RA. 1999. Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. J. Gen. Virol. 80(Pt 8):2121-2126.
30. Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, Kaluza G, Pumpens P, Gerlich WH. 2000. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J. Gen. Virol. 81:369-378.
31. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S, Ahlquist P. 2007. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc. Natl. Acad. Sci. U. S. A. 104:10205-10210. http://dx.doi.org/10.1073/pnas.0704000104.
32. Abou-Jaoude G, Sureau C. 2007. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J. Virol. 81:13057-13066. http://dx.doi.org/10.1128/JVI.01495-07.
33. Sureau C, Salisse J. 2013. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant. Hepatology 57:985-994. http://dx.doi.org/10.1002/hep.26125.
34. Bruss V, Ganem D. 1991. The role of envelope proteins in hepatitis B virus assembly. Proc. Natl. Acad. Sci. U. S. A. 88:1059-1063. http://dx.doi.org/10.1073/pnas.88.3.1059.
35. Kwei K, Tang X, Lok AS, Sureau C, Garcia T, Li J, Wands J, Tong S. 2013. Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation. J. Virol. 87:2352-2357. http://dx.doi.org/10.1128/JVI.02701-12.
36. Bruss V. 1997. A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J. Virol. 71:9350-9357.
37. Yu SL, Yu DM, Zhang DH, Jiang JH, Chen J, Deng L, Zhang XX. 2013. Functional analysis of hepatitis B virus immune escape mutants with insertion mutations in the surface antigen. Zhonghua Gan Zang Bing Za Zhi 21:510-513. (In Chinese.) doi: http://dx.doi.org/10.3760/cma.j.issn.1007-3418.2013.07.009.
38. Raimondo G, Caccamo G, Filomia R, Pollicino T. 2013. Occult HBV infection. Semin. Immunopathol. 35:39-52. http://dx.doi.org/10.1007/s00281-012-0327-7.
39. Nilsson I, von Heijne G. 2000. Glycosylation efficiency of Asn-Xaa-Thr sequons depends both on the distance from the C terminus and on the presence of a downstream transmembrane segment. J. Biol. Chem. 275: 17338-17343. http://dx.doi.org/10.1074/jbc.M002317200.
40. Mangold CM, Streeck RE. 1993. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J. Virol. 67:4588-4597.
41. Steward MW, Partidos CD, D'Mello F, Howard CR. 1993. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine 11:1405-1414. http://dx.doi.org/10.1016/0264-410X(93)90169-X.